Is Oxymetholone a suitable compound for someone on their very first anabolic cycle?

Oxymetholone is a potent 17α-alkylated oral androgen and is generally not recommended as a first-ever anabolic compound for athletes who have no prior bloodwork baseline or cycle experience. However, for those who have completed at least one testosterone-only cycle, have current liver and lipid panels on file, and understand post-cycle therapy requirements, a low-dose Oxymetholone introduction at 20–30 mg per day using the 10 mg tablet format is the most controlled entry method available.

What daily dose do harm-reduction guidelines suggest for a first-time Oxymetholone user?

Current harm-reduction frameworks for Oxymetholone-naive athletes point to 20–30 mg per day as the appropriate starting range, maintained for no longer than four weeks. The 10 mg/tab format supports this directly: two tablets deliver 20 mg, three tablets deliver 30 mg — both are whole-tablet doses requiring no splitting. Week-by-week escalation, guided by ALT/AST readings at week two, allows dose adjustment in precise 10 mg steps not achievable with higher-concentration tablets.

What should a newcomer know about liver monitoring before starting an Oxymetholone cycle?

Before the first tablet, a baseline liver enzyme panel — ALT and AST at minimum — is mandatory. Oxymetholone is a 17α-alkylated oral compound, meaning hepatic enzyme elevation is expected; the question is magnitude. Beginners should retest at week two and week four. Any ALT or AST reading exceeding twice the upper reference limit at the week-two check is a clear signal to reduce the daily dose by one 10 mg tablet rather than continue on the planned schedule.

Why is the 10 mg per tablet concentration the best choice for first-cycle Oxymetholone users compared to 50 mg tablets?

The 10 mg unit dose provides a fivefold improvement in dose-adjustment resolution compared to a 50 mg tablet. A beginner can begin at 20 mg (two tablets), move to 30 mg (three tablets), and if bloodwork supports it, reach 40 mg (four tablets) — all using whole, analytically uniform tablets. Splitting a 50 mg tablet to achieve these increments introduces API distribution uncertainty that the 10 mg format eliminates by design.

Can Rossiaz Lab Oxymetholone 10mg tablets be physically split for doses below 10 mg, and does tablet uniformity support that?

The 10 mg unit is already the lowest concentration available in the Oxymetholone category, and Rossiaz Lab's fill-weight and API uniformity controls are calibrated to the whole-tablet dose. While physical splitting is mechanically possible, the tablet is not scored for splitting, and sub-10 mg fractions would fall outside the precision the manufacturing process is designed to guarantee. Beginners requiring less than 10 mg per dose should reconsider whether Oxymetholone is the appropriate compound at this stage. (2) angle_used

Athletes' Choice

Rossiaz Lab

Oxymetholone 10mg/tab 100 Tabletten by Rossiaz Lab

Name: Oxymetholone 10mg/tab 100 Tablets by Rossiaz Lab
Brand: Rossiaz Lab
SKU: ORA-OXYM-ROS-024
Price: 80.00 EUR
Availability: InStock

Rossiaz Lab Oxymetholone 10mg/tab is a low-unit-dose oral anabolic tablet — each unit delivering 10 mg of Oxymetholone — specifically suited to first-cycle athletes who need incremental dose control that standard 50 mg tablets cannot provide. The 100-tablet count at this concentration gives newcomers the flexibility to begin conservatively and adjust weekly without splitting tablets or estimating fractions. Every production batch is released against a lot-traceable Certificate of Analysis: reversed-phase HPLC potency verification and LAL endotoxin clearance are completed before dispatch.

€80.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Lowest unit dose in the Oxymetholone category — 10 mg per tablet enables whole-tablet precision without splitting
100-tablet count provides sufficient supply for a full four-week cycle plus a conservative one-week titration ramp
HPLC-verified API content at batch level ensures each tablet delivers the declared 10 mg, not an approximation
LAL endotoxin clearance applied to incoming raw material before tablet compression, not inferred from finished-product sampling
Reversible weekly dose steps of 10 mg allow newcomers to respond to bloodwork data in real time
DHT-derived structure means no aromatisation-driven fluid accumulation from the oral compound itself, simplifying side-effect attribution for first-time users
Individually blister-packed units protect tablet integrity and support accurate dose counting across the cycle

Phase	Daily Dose	Note
Week 1 — Orientation	20 mg (2 × 10 mg tablets)	Establish tolerance baseline; no dose change before week-two bloodwork
Week 2 — Assessment	20–30 mg (2–3 × 10 mg tablets)	Escalate to 30 mg only if ALT/AST remain below 2× upper reference limit at week-two panel
Week 3 — Moderate Exposure	30–40 mg (3–4 × 10 mg tablets)	40 mg ceiling for first-cycle users; do not exceed without prior cycle experience and clean liver markers
Week 4 — Final Window	30–40 mg (maintain week-3 dose)	No further escalation in week 4; plan post-cycle therapy start for day 1 after last tablet
Post-Cycle	0 mg Oxymetholone	Begin Nolvadex 40/40/20/20 mg or Clomid 50/50/25/25 mg protocol immediately after last dose

Key takeaways

Start at 20–30 mg daily using whole 10 mg tablets for exact beginner titration.
Run baseline bloodwork before day one — ALT, AST, haematocrit, lipids.
Limit first-cycle duration to four weeks to manage cumulative hepatic exposure.
Escalate dose by one tablet per week only if week-two biomarkers permit.
Secure post-cycle therapy (Nolvadex or Clomid) before swallowing the first tablet.

Oxymetholone 10mg/tab: The Entry-Level Format Designed for First-Cycle Precision

Rossiaz Lab Oxymetholone 10mg/tab is an oral anabolic compound manufactured in a deliberately low unit dose so that athletes beginning their first exposure to Oxymetholone can calibrate daily intake in 10 mg increments without relying on tablet splitting or approximation. The active substance belongs to the DHT-derived 17α-alkylated androgen class, carries an approximate plasma elimination window of 8–9 hours based on chromatographic plasma-assay methodology, and reaches measurable peak concentration within roughly one to two hours of oral administration under typical fasting conditions. These pharmacokinetic characteristics are relevant to beginners because they define when daily effects are felt and how quickly the compound clears between doses.

Why the 10 mg Unit Dose Matters for Newcomers

The 10 mg per tablet format delivers a practical advantage no other concentration in the Oxymetholone category replicates: a first-time user can begin at 20–30 mg per day by taking two or three whole, analytically uniform tablets, then step up by a single tablet increment each week based on observed tolerance. Compared to a 50 mg tablet format, this approach reduces the minimum adjustable dose unit from 50 mg to 10 mg — a fivefold improvement in titration resolution. Rossiaz Lab's tablet compression process applies fill-weight tolerances and API uniformity standards that ensure each 10 mg unit contains the declared quantity rather than a fraction that varies across positions in the blister sheet.

Beginner Safety Benchmarks: What the Numbers Mean

First-cycle harm-reduction practice establishes a starting daily range of 20–30 mg for Oxymetholone-naive athletes, with duration capped at four weeks to limit cumulative hepatic enzyme exposure. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) should be measured at baseline and again at week two and week four; any reading above twice the upper reference limit at week two warrants dose reduction rather than continuation. Haematocrit should be checked at the same intervals because Oxymetholone promotes erythropoiesis — measurable red-cell mass elevation can occur within the first two weeks of oral administration. The 10 mg tablet unit allows a beginner to implement a structured week-by-week escalation: 20 mg in week one, 30 mg in week two, and — only if biomarker data support it — 40 mg in weeks three and four, without ever touching a pill cutter.

What Beginners Must Prepare Before Week One

A pre-cycle bloodwork panel covering liver enzymes, lipid profile, haematocrit, and testosterone reference values is non-negotiable before a first Oxymetholone cycle. Rossiaz Lab Oxymetholone 10mg/tab supports this discipline by making the first dose a round, measurable unit rather than an estimated half-tablet. Post-cycle therapy planning — typically a four-week Nolvadex or Clomid protocol — should be purchased and on hand before cycle day one, since endogenous testosterone suppression begins within the first week of administration.

Usage

Complete a pre-cycle bloodwork panel — ALT, AST, haematocrit, total cholesterol, HDL, LDL, and baseline testosterone — at least five days before the first tablet.
Take the daily dose as two whole 10 mg tablets with a moderate-sized meal to support gastric tolerance; avoid high-fat meals exceeding 30 g at the time of dosing to prevent delayed absorption.
Administer the full daily dose at the same time each day, preferably in the morning, to align androgenic activity with the natural daytime training and recovery window.
At the end of week two, repeat ALT, AST, and haematocrit; review results before deciding whether to advance from 20 mg to 30 mg in week three.
Do not combine Oxymetholone with any second 17α-alkylated oral compound during a first cycle — stacking two orals compounds additive hepatic enzyme burden that cannot be attributed or managed cleanly at the beginner stage.
Have post-cycle therapy medication — Nolvadex or Clomid — in hand from day one of the cycle, and begin the PCT protocol on the morning after the last Oxymetholone tablet.

Warnings

Contraindications: Oxymetholone 10mg/tab is contraindicated in individuals with existing liver disease, elevated baseline ALT or AST (any reading above the upper reference limit before cycle start), carcinoma of the prostate or breast, hypercalcaemia, nephrotic syndrome, or pregnancy. First-cycle athletes under the age of 21 should not use this compound due to unresolved epiphyseal plate status and incomplete hormonal axis maturity.

Side_Effects: Expected side effects in beginners include suppression of endogenous testosterone production (onset within the first week), elevation of liver enzymes (ALT/AST), increased haematocrit, HDL cholesterol reduction, potential fluid retention, and increased blood pressure. The 10 mg tablet format reduces the risk of inadvertent overdose but does not eliminate the compound's intrinsic hepatotoxic and cardiovascular risk profile.

Monitoring: Mandatory monitoring for first-cycle users: baseline bloodwork before day one; repeat liver enzyme and haematocrit panel at week two and week four; lipid panel at week four. Any ALT or AST reading exceeding twice the upper reference limit is a dose-reduction signal. Haematocrit readings above 52 % require immediate dose reduction and medical review. Blood pressure should be self-monitored weekly with a calibrated cuff.

PCT: Post-cycle therapy is mandatory after any Oxymetholone cycle, including short beginner runs. A standard protocol — Nolvadex 40 mg daily for two weeks followed by 20 mg daily for two weeks, or Clomid 50 mg daily for two weeks followed by 25 mg daily for two weeks — should begin the day after the last Oxymetholone tablet. A post-PCT testosterone panel at week four of recovery confirms endogenous axis restoration.

Frequently asked questions

Is Oxymetholone a suitable compound for someone on their very first anabolic cycle?: Oxymetholone is a potent 17α-alkylated oral androgen and is generally not recommended as a first-ever anabolic compound for athletes who have no prior bloodwork baseline or cycle experience. However, for those who have completed at least one testosterone-only cycle, have current liver and lipid panels on file, and understand post-cycle therapy requirements, a low-dose Oxymetholone introduction at 20–30 mg per day using the 10 mg tablet format is the most controlled entry method available.
What daily dose do harm-reduction guidelines suggest for a first-time Oxymetholone user?: Current harm-reduction frameworks for Oxymetholone-naive athletes point to 20–30 mg per day as the appropriate starting range, maintained for no longer than four weeks. The 10 mg/tab format supports this directly: two tablets deliver 20 mg, three tablets deliver 30 mg — both are whole-tablet doses requiring no splitting. Week-by-week escalation, guided by ALT/AST readings at week two, allows dose adjustment in precise 10 mg steps not achievable with higher-concentration tablets.
What should a newcomer know about liver monitoring before starting an Oxymetholone cycle?: Before the first tablet, a baseline liver enzyme panel — ALT and AST at minimum — is mandatory. Oxymetholone is a 17α-alkylated oral compound, meaning hepatic enzyme elevation is expected; the question is magnitude. Beginners should retest at week two and week four. Any ALT or AST reading exceeding twice the upper reference limit at the week-two check is a clear signal to reduce the daily dose by one 10 mg tablet rather than continue on the planned schedule.
Why is the 10 mg per tablet concentration the best choice for first-cycle Oxymetholone users compared to 50 mg tablets?: The 10 mg unit dose provides a fivefold improvement in dose-adjustment resolution compared to a 50 mg tablet. A beginner can begin at 20 mg (two tablets), move to 30 mg (three tablets), and if bloodwork supports it, reach 40 mg (four tablets) — all using whole, analytically uniform tablets. Splitting a 50 mg tablet to achieve these increments introduces API distribution uncertainty that the 10 mg format eliminates by design.
Can Rossiaz Lab Oxymetholone 10mg tablets be physically split for doses below 10 mg, and does tablet uniformity support that?: The 10 mg unit is already the lowest concentration available in the Oxymetholone category, and Rossiaz Lab's fill-weight and API uniformity controls are calibrated to the whole-tablet dose. While physical splitting is mechanically possible, the tablet is not scored for splitting, and sub-10 mg fractions would fall outside the precision the manufacturing process is designed to guarantee. Beginners requiring less than 10 mg per dose should reconsider whether Oxymetholone is the appropriate compound at this stage. (2) angle_used

Manufacturer

Rossiaz Lab's quality control architecture for its oral tablet line is built around a specific problem that matters most to precision-dose users: fill-weight consistency at low API concentrations. For Oxymetholone 10mg/tab, the declared 10 mg per unit is a smaller absolute mass than the 50 mg formats that dominate the category — which means that any deviation from target fill weight represents a proportionally larger percentage error per tablet. Rossiaz Lab addresses this by applying tighter granulate homogeneity controls during the blending stage and by submitting finished tablets from each production batch to reversed-phase HPLC content-uniformity analysis, with acceptance criteria referenced against pharmacopoeial tablet-uniformity standards rather than against general API purity specifications alone. LAL endotoxin screening on incoming Oxymetholone API adds a further pre-compression verification layer. The result is a 10 mg tablet format whose declared content is supported by analytical data specific to the finished dosage unit — relevant for beginners whose entire dose-titration strategy depends on the assumption that tablet one and tablet ten from the same blister strip contain equal quantities of active compound.

Product details

Brand	Rossiaz Lab
Active ingredient	oxymetholone
Also known as	Anadrol, Anapolon, Oxymetholone, Oxymetholonee, Rossiaz Lab Anadrol
Strength	10 mg
Form	Tabletten
Pack size	100 pieces
Item number	ORA-OXYM-ROS-024

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Anapolon 50mg/tab 20 Tablets by Abdi Ibrahim

Lab Tested

Anapolon 50mg/tab 20 Tabletten by Abdi Ibrahim

Anapolon (Oxymetholone) by Abdi Ibrahim is a 17α-alkylated dihydrotestosterone-derived oral anabolic steroid, dosed at 50 mg per tablet across 20 tablets, whose primary pharmacological identity is defined by its high-affinity interaction with androgen receptors combined with a marked capacity to stimulate erythropoietin production. As a DHT-lineage compound, Oxymetholone cannot be aromatised directly yet drives powerful anabolic signalling through androgen receptor activation and progesterone receptor cross-reactivity. Quality is enforced at every production stage: HPLC purity verification, LAL endotoxin testing, and GMP-certified manufacturing conditions underpin every blister pack released by Abdi Ibrahim.

€20.00

Anapolon 50mg/tab 60 Tablets by Balkan Pharmaceuticals

HPLC Verified

Anapolon 50mg/tab 60 Tabletten by Balkan Pharmaceuticals

Anapolon by Balkan Pharmaceuticals is an oral anabolic tablet delivering 50 mg of Oxymetholone per dose, clinically characterised by a plasma half-life of approximately 8–9 hours that governs its twice-daily administration schedule. The pharmacokinetic profile allows predictable plasma-level maintenance without the accumulation spikes associated with longer-half-life oral androgens, making timed dosing a core performance variable. Batch-release integrity is enforced through post-compression HPLC quantification and LAL endotoxin screening — each of the 60 tablets verified against declared potency before dispatch.

€48.00

Pro-Anadrol 50mg/tab 50 Tablets by Beligas Pharmaceuticals

Pharma Grade

Pro-Anadrol 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

Pro-Anadrol delivers Oxymetholone at 50 mg per tablet across a 50-tablet pack — an oral androgen whose systemic bioavailability is shaped entirely by first-pass hepatic metabolism, distinguishing its absorption profile sharply from any injectable androgenic compound. Because the molecule must survive gastrointestinal transit and initial liver processing before entering systemic circulation, oral Oxymetholone achieves estimated bioavailability in the 56–70 % range, a figure that injectable routes bypass entirely by delivering the active substance directly into the bloodstream. Batch-level potency is confirmed at Beligas Pharmaceuticals through HPLC quantification against certified pharmacopoeial reference standards, with LAL endotoxin screening applied to raw excipient inputs before tableting proceeds.

€60.00

OxyTrex 25mg/tab 100 Tablets by Concentrex Labs

Purity Tested

OxyTrex 25mg/tab 100 Tabletten by Concentrex Labs

OxyTrex by Concentrex Labs delivers Oxymetholone at 25 mg per tablet across 100 tablets, formulated specifically for athletes studying how this potent oral androgen interacts with insulin sensitivity and glucose partitioning during hypertrophic loading phases. Oxymetholone's documented capacity to alter nutrient uptake dynamics — shifting glucose disposal toward skeletal muscle — makes it a subject of sustained interest in metabolic-context bodybuilding literature. Purity Tested at the finished-tablet stage via HPLC quantification; each released lot carries a batch record confirming active-content compliance against a certified reference standard.

€60.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00